[{"address1": "Modi\u2019in Technology Park", "address2": "2 HaMa\u2019ayan Street", "city": "Hevel Modi'in", "zip": "7177871", "country": "Israel", "phone": "972 8 642 9100", "fax": "972 8 642 9101", "website": "https://www.biolinerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA", "age": 64, "title": "Chief Executive Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 499000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ella  Sorani Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 295000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Lacey", "title": "Head of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raziel  Fried", "title": "Treasurer & Budgetary Control Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.74, "open": 3.6407, "dayLow": 3.61, "dayHigh": 3.79, "regularMarketPreviousClose": 3.74, "regularMarketOpen": 3.6407, "regularMarketDayLow": 3.61, "regularMarketDayHigh": 3.79, "payoutRatio": 0.0, "beta": 0.882, "forwardPE": -17.227272, "volume": 7765, "regularMarketVolume": 7765, "averageVolume": 105492, "averageVolume10days": 32660, "averageDailyVolume10Day": 32660, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 16155557, "fiftyTwoWeekLow": 2.3, "fiftyTwoWeekHigh": 26.8, "priceToSalesTrailing12Months": 0.9364997, "fiftyDayAverage": 4.1502, "twoHundredDayAverage": 5.3211, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9677790208, "profitMargins": -0.45341998, "floatShares": 2450907651, "sharesOutstanding": 4262680, "sharesShort": 203233, "sharesShortPriorMonth": 189833, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0477, "heldPercentInsiders": 0.04078, "heldPercentInstitutions": 0.0155299995, "shortRatio": 5.51, "shortPercentOfFloat": 0.0478, "impliedSharesOutstanding": 3710940, "bookValue": 0.008, "priceToBook": 473.74997, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -7822000, "trailingEps": -6.0, "forwardEps": -0.22, "lastSplitFactor": "1:40", "lastSplitDate": 1738195200, "enterpriseToRevenue": 560.999, "enterpriseToEbitda": -893.609, "52WeekChange": -0.8496032, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 3.79, "targetHighPrice": 40.0, "targetLowPrice": 12.0, "targetMeanPrice": 26.0, "targetMedianPrice": 26.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 28159000, "totalCashPerShare": 0.011, "ebitda": -10830000, "totalDebt": 12603000, "quickRatio": 1.837, "currentRatio": 2.058, "totalRevenue": 17251000, "debtToEquity": 62.789, "revenuePerShare": 6.0, "returnOnAssets": -0.15356, "returnOnEquity": -0.4594, "grossProfits": 10234000, "freeCashflow": -11746375, "operatingCashflow": -21203000, "revenueGrowth": -0.944, "grossMargins": 0.59324, "ebitdaMargins": -0.62779, "operatingMargins": -7.5756598, "financialCurrency": "USD", "symbol": "BLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_5015080", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1756502160, "regularMarketTime": 1756497600, "shortName": "BioLineRx Ltd.", "longName": "BioLineRx Ltd.", "regularMarketChangePercent": 1.336897, "regularMarketPrice": 3.79, "postMarketChangePercent": -6.39842, "postMarketPrice": 3.5475, "postMarketChange": -0.2425, "regularMarketChange": 0.049999952, "regularMarketDayRange": "3.61 - 3.79", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 105492, "fiftyTwoWeekLowChange": 1.49, "fiftyTwoWeekLowChangePercent": 0.6478261, "fiftyTwoWeekRange": "2.3 - 26.8", "fiftyTwoWeekHighChange": -23.009998, "fiftyTwoWeekHighChangePercent": -0.8585821, "fiftyTwoWeekChangePercent": -84.96032, "dividendDate": 1563148800, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "earningsCallTimestampStart": 1755174600, "earningsCallTimestampEnd": 1755174600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.0, "epsForward": -0.22, "epsCurrentYear": -0.795, "priceEpsCurrentYear": -4.7672954, "fiftyDayAverageChange": -0.36019993, "fiftyDayAverageChangePercent": -0.08679099, "twoHundredDayAverageChange": -1.5311003, "twoHundredDayAverageChangePercent": -0.2877413, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1311773400000, "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]